(Q36104706)

English

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

hypercholesterolemia

0 references

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Robert A. Hegele

6

object named as

Robert A Hegele

0 references

Giovanni B Vigna

object named as

Giovanni B Vigna

12

0 references

object named as

Dirk J Blom

4

0 references

Maurizio Averna

object named as

Maurizio R Averna

7

0 references

author name string

Marina Cuchel

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Emma A Meagher

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hendrik du Toit Theron

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

A David Marais

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Cesare R Sirtori

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Prediman K Shah

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Daniel Gaudet

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Claudia Stefanutti

11

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Anna M E Du Plessis

13

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Kathleen J Propert

14

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

William J Sasiela

15

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

LeAnne T Bloedon

16

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Daniel J Rader

17

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Phase 3 HoFH Lomitapide Study investigators

18

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

2 November 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

381

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

9860

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

40-46

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 October 2017

Preemptive liver transplantation in a child with familial hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 October 2017

Efficacy criteria and cholesterol targets for LDL apheresis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 October 2017

Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 October 2017

Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 October 2017

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 October 2017

Homozygous familial hypercholesterolemia and its management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 October 2017

Monogenic hypercholesterolemia: new insights in pathogenesis and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 October 2017

LDL Apheresis: an effective and safe treatment for refractory hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 October 2017

Microsomal triglyceride transfer protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 October 2017

Heart-liver transplantation in a patient with familial hypercholesterolaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 October 2017

Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

2 July 2018

Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

23 September 2018

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

23 September 2018

Treatment of symptomatic HyperLp(a)lipoproteinemia with LDL-apheresis: a multicentre study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

23 September 2018

Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

23 September 2018

A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

23 September 2018

Long-term effects of LDL apheresis in patients with severe hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

23 September 2018

Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4587657

23 September 2018

Homozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961731-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961731-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961731-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Three different LDL apheresis columns efficiently and equally reduce lipoprotein(a) concentrations in patients with familial hypercholesterolemia and small apolipoprotein(a) particles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961731-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)61731-0

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36104706&oldid=2041809065"